These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 34015381

  • 1. Microfluidic-assisted fabrication of phosphatidylcholine-based liposomes for controlled drug delivery of chemotherapeutics.
    Gkionis L, Aojula H, Harris LK, Tirella A.
    Int J Pharm; 2021 Jul 15; 604():120711. PubMed ID: 34015381
    [Abstract] [Full Text] [Related]

  • 2. Manufacturing drug co-loaded liposomal formulations targeting breast cancer: Influence of preparative method on liposomes characteristics and in vitro toxicity.
    Gkionis L, Campbell RA, Aojula H, Harris LK, Tirella A.
    Int J Pharm; 2020 Nov 30; 590():119926. PubMed ID: 33010397
    [Abstract] [Full Text] [Related]

  • 3. Sterically stabilized liposomes production using staggered herringbone micromixer: Effect of lipid composition and PEG-lipid content.
    Cheung CCL, Al-Jamal WT.
    Int J Pharm; 2019 Jul 20; 566():687-696. PubMed ID: 31212051
    [Abstract] [Full Text] [Related]

  • 4. A study on the role of cholesterol and phosphatidylcholine in various features of liposomal doxorubicin: From liposomal preparation to therapy.
    Farzaneh H, Ebrahimi Nik M, Mashreghi M, Saberi Z, Jaafari MR, Teymouri M.
    Int J Pharm; 2018 Nov 15; 551(1-2):300-308. PubMed ID: 30243944
    [Abstract] [Full Text] [Related]

  • 5. Manufacturing of 3D-Printed Microfluidic Devices for the Synthesis of Drug-Loaded Liposomal Formulations.
    Ballacchino G, Weaver E, Mathew E, Dorati R, Genta I, Conti B, Lamprou DA.
    Int J Mol Sci; 2021 Jul 28; 22(15):. PubMed ID: 34360832
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The Manufacturing and Characterisation of Eugenol-Enclosed Liposomes Produced by Microfluidic Method.
    Ghodke J, Ekonomou SI, Weaver E, Lamprou D, Doran O, Stratakos AC.
    Foods; 2023 Aug 03; 12(15):. PubMed ID: 37569209
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Peptide-modified liposomes for selective targeting of bombesin receptors overexpressed by cancer cells: a potential theranostic agent.
    Accardo A, Salsano G, Morisco A, Aurilio M, Parisi A, Maione F, Cicala C, Tesauro D, Aloj L, De Rosa G, Morelli G.
    Int J Nanomedicine; 2012 Aug 03; 7():2007-17. PubMed ID: 22619538
    [Abstract] [Full Text] [Related]

  • 10. A simple passive equilibration method for loading carboplatin into pre-formed liposomes incubated with ethanol as a temperature dependent permeability enhancer.
    Wehbe M, Malhotra A, Anantha M, Roosendaal J, Leung AWY, Plackett D, Edwards K, Gilabert-Oriol R, Bally MB.
    J Control Release; 2017 Apr 28; 252():50-61. PubMed ID: 28286316
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Rapid scale-up and production of active-loaded PEGylated liposomes.
    Roces CB, Port EC, Daskalakis NN, Watts JA, Aylott JW, Halbert GW, Perrie Y.
    Int J Pharm; 2020 Aug 30; 586():119566. PubMed ID: 32622812
    [Abstract] [Full Text] [Related]

  • 13. Microfluidic manufacturing of phospholipid nanoparticles: Stability, encapsulation efficacy, and drug release.
    Guimarães Sá Correia M, Briuglia ML, Niosi F, Lamprou DA.
    Int J Pharm; 2017 Jan 10; 516(1-2):91-99. PubMed ID: 27840162
    [Abstract] [Full Text] [Related]

  • 14. Investigation of factors affecting controlled release from photosensitive DMPC and DSPC liposomes.
    Aygun A, Torrey K, Kumar A, Stephenson LD.
    Appl Biochem Biotechnol; 2012 Jun 10; 167(4):743-57. PubMed ID: 22592778
    [Abstract] [Full Text] [Related]

  • 15. Microfluidic-assisted bacteriophage encapsulation into liposomes.
    Leung SSY, Morales S, Britton W, Kutter E, Chan HK.
    Int J Pharm; 2018 Jul 10; 545(1-2):176-182. PubMed ID: 29729404
    [Abstract] [Full Text] [Related]

  • 16. Role of drug release and liposome-mediated drug delivery in governing the therapeutic activity of liposomal mitoxantrone used to treat human A431 and LS180 solid tumors.
    Lim HJ, Masin D, McIntosh NL, Madden TD, Bally MB.
    J Pharmacol Exp Ther; 2000 Jan 10; 292(1):337-45. PubMed ID: 10604968
    [Abstract] [Full Text] [Related]

  • 17. Liposomal Doxorubicin Delivery Systems: Effects of Formulation and Processing Parameters on Drug Loading and Release Behavior.
    Mohammadi ZA, Aghamiri SF, Zarrabi A, Talaie MR.
    Curr Drug Deliv; 2016 Jan 10; 13(7):1065-1070. PubMed ID: 26708673
    [Abstract] [Full Text] [Related]

  • 18. Calcein release behavior from liposomal bilayer; influence of physicochemical/mechanical/structural properties of lipids.
    Maherani B, Arab-Tehrany E, Kheirolomoom A, Geny D, Linder M.
    Biochimie; 2013 Nov 10; 95(11):2018-33. PubMed ID: 23871914
    [Abstract] [Full Text] [Related]

  • 19. Microfluidic paclitaxel-loaded lipid nanoparticle formulations for chemotherapy.
    Jaradat E, Weaver E, Meziane A, Lamprou DA.
    Int J Pharm; 2022 Nov 25; 628():122320. PubMed ID: 36272514
    [Abstract] [Full Text] [Related]

  • 20. High-throughput manufacturing of size-tuned liposomes by a new microfluidics method using enhanced statistical tools for characterization.
    Kastner E, Kaur R, Lowry D, Moghaddam B, Wilkinson A, Perrie Y.
    Int J Pharm; 2014 Dec 30; 477(1-2):361-8. PubMed ID: 25455778
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.